News

In addition to providing the capability to conduct a variety of studies in healthy volunteers, the core focus of the Port Elizabeth unit is on early phase studies

NEBNext reagents are a series of highly pure reagents that facilitate sample preparation for downstream applications, such as next generation sequencing. All reagents undergo stringent quality controls and

Source BioScience will provide infrastructure and technology platforms in addition to employing technical staff and expertise to operate the Dublin facility, with further support available from its main

Earlier, in 2009, eight products manufactured by China Sky One Medical’s main operating subsidiary, Harbin Tian Di Ren Medical Science and Technology Company (TDR) were included on the

The ORBIT-1 trial will randomize 96 patients, who will receive for four weeks either one of two different once-daily inhaled doses (100 or 150mg ciprofloxacin delivered by inhalation

CORT 108297 is the lead compound from our three series of proprietary selective GR-II antagonists and is a fused-ring azadecalin. This series of compounds has demonstrated a greater

The study, conducted at Jolimont Hospital in Haine Saint Paul, Belgium, prospectively evaluated MTWA in 73 consecutive patients who met criteria for implantable cardioverter defibrillator implantation for primary

The goal of the ACRG is to improve the knowledge of cancers prevalent in Asia and to accelerate drug discovery efforts by freely sharing the resulting data with

NanoGuardian’s NanoEncryption technology works directly on capsules, tablets, vial caps, and single-use syringes to provide a layered security strategy consisting of overt, covert and forensic security features. NanoGuardian